Fang, H., Guinto, H., & Pinneboina, H. (2023). Effective Reprogramming Strategies for Treating Diabetes-Related Cancer: A Focus on Fasentin, Metformin, and Panitumumab Therapies. Berkeley Pharma Tech Journal of Medicine, 3(2), 101–118. https://doi.org/10.52243/bptjm.v3i2.46